Featured PGRN Investigators

Dr. Scott is an Associate Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York, and is a Laboratory Director and Division Head of Pharmacogenomics at Sema4 (previously the Mount Sinai Genetic Testing Laboratory). He is certified by the American Board of Medical Genetics and Genomics (ABMGG) in both Clinical Molecular Genetics and Clinical Cytogenetics and Genomics, and his research interests include pharmacogenomics, cytogenomics, long-read sequencing, and the implementation of genomic medicine. Dr. Scott is also a member of the Institute for Personalized Medicine (IPM) at Mount Sinai, where he serves on the pharmacogenomics implementation team. Additionally, he is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), ClinGen, eMERGE/IGNITE, PharmVar, International Union of Basic and Clinical Pharmacology (IUPHAR), and other national and international pharmacogenomics consortia.

Associate ProfessorIcahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciencesstuart.scott@mssm.edu

He is the co-editor of Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation (2nd edition), and his notable honors include the 2011 William Bowes Jr Award in Medical Genetics from Partners HealthCare Center for Personalized Genetic Medicine, and the 2012 Dr. Harold and Golden Lamport Research Award from the Icahn School of Medicine at Mount Sinai.